Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Oct;110(2):747–752. doi: 10.1111/j.1476-5381.1993.tb13875.x

Activation of the phospholipase C pathway by ATP is mediated exclusively through nucleotide type P2-purinoceptors in C2C12 myotubes.

R H Henning 1, M Duin 1, A den Hertog 1, A Nelemans 1
PMCID: PMC2175950  PMID: 8242247

Abstract

1. The presence of a nucleotide receptor and a discrete ATP-sensitive receptor on C2C12 myotubes has been shown by electrophysiological experiments. In this study, the ATP-sensitive receptors of C2C12 myotubes were further characterized by measuring the formation of inositol(1,4,5)trisphosphate (Ins(1,4,5)P3) and internal Ca2+. 2. The nucleotides ATP and UTP caused a concentration-dependent increase in Ins(1,4,5)P3 content with comparable time courses (EC50: ATP 33 +/- 2 microM, UTP 80 +/- 4 microM). ADP was less effective in increasing Ins(1,4,5)P3 content of the cells, while selective agonists for P1-, P2X- and P2Y-purinoceptors, adenosine, alpha,beta-methylene ATP and 2-methylthio ATP, appeared to be ineffective. 3. Under Ca(2+)-free conditions, the basal level of Ins(1,4,5)P3 was lower than in the presence of Ca2+, and the ATP- and UTP-induced formation of Ins(1,4,5)P3 was diminished. 4. The Ins(1,4,5)P3 formation induced by optimal ATP and UTP concentrations was not additive. ATP- and UTP-induced Ins(1,4,5)P3 formation showed cross-desensitization, whereas cross-desensitization was absent in responses elicited by one of the nucleotides and bradykinin. 5. The change in Ins(1,4,5)P3 content induced by effective nucleotides was inhibited by suramin. Schild plots for suramin inhibition of Ins(1,4,5)P3 formation in ATP- and UTP-stimulated myotubes showed slopes greater than unity (1.63 +/- 0.09 and 1.37 +/- 0.11, respectively). Apparent pA2 values were 4.50 +/- 0.48 and 4.41 +/- 0.63 for ATP and UTP, respectively. 6. Stimulation of the cells with ATP or UTP induced a rapid increase in intracellular Ca2+, followed by a slow decline to basal levels. Ca2+ responses reached lower maximal values and did not show the slow phase in the absence of extracellular Ca2+.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
747

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baukal A. J., Balla T., Hunyady L., Hausdorff W., Guillemette G., Catt K. J. Angiotensin II and guanine nucleotides stimulate formation of inositol 1,4,5-trisphosphate and its metabolites in permeabilized adrenal glomerulosa cells. J Biol Chem. 1988 May 5;263(13):6087–6092. [PubMed] [Google Scholar]
  2. Berridge M. J. Inositol trisphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem. 1987;56:159–193. doi: 10.1146/annurev.bi.56.070187.001111. [DOI] [PubMed] [Google Scholar]
  3. Berridge M. J., Irvine R. F. Inositol phosphates and cell signalling. Nature. 1989 Sep 21;341(6239):197–205. doi: 10.1038/341197a0. [DOI] [PubMed] [Google Scholar]
  4. Biden T. J., Wollheim C. B. Ca2+ regulates the inositol tris/tetrakisphosphate pathway in intact and broken preparations of insulin-secreting RINm5F cells. J Biol Chem. 1986 Sep 15;261(26):11931–11934. [PubMed] [Google Scholar]
  5. Burnstock G. Overview. Purinergic mechanisms. Ann N Y Acad Sci. 1990;603:1–18. doi: 10.1111/j.1749-6632.1990.tb37657.x. [DOI] [PubMed] [Google Scholar]
  6. Cusack N. J., Hourani S. M. Subtypes of P2-purinoceptors. Studies using analogues of ATP. Ann N Y Acad Sci. 1990;603:172–181. doi: 10.1111/j.1749-6632.1990.tb37671.x. [DOI] [PubMed] [Google Scholar]
  7. Davidson J. S., Wakefield I. K., Sohnius U., van der Merwe P. A., Millar R. P. A novel extracellular nucleotide receptor coupled to phosphoinositidase-C in pituitary cells. Endocrinology. 1990 Jan;126(1):80–87. doi: 10.1210/endo-126-1-80. [DOI] [PubMed] [Google Scholar]
  8. Den Hertog A., Hoiting B., Molleman A., Van den Akker J., Duin M., Nelemans A. Calcium release from separate receptor-specific intracellular stores induced by histamine and ATP in a hamster cell line. J Physiol. 1992 Aug;454:591–607. doi: 10.1113/jphysiol.1992.sp019281. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Eriksson H., Heilbronn E. Extracellularly applied ATP alters the calcium flux through dihydropyridine-sensitive channels in cultured chick myotubes. Biochem Biophys Res Commun. 1989 Mar 31;159(3):878–885. doi: 10.1016/0006-291x(89)92190-6. [DOI] [PubMed] [Google Scholar]
  10. Henning R. H., Nelemans A., Scaf A. H., Van Eekeren J., Agoston S., Den Hertog A. Suramin reverses non-depolarizing neuromuscular blockade in rat diaphragm. Eur J Pharmacol. 1992 May 27;216(1):73–79. doi: 10.1016/0014-2999(92)90211-l. [DOI] [PubMed] [Google Scholar]
  11. Henning R. H., Nelemans A., van den Akker J., den Hertog A. The nucleotide receptors on mouse C2C12 myotubes. Br J Pharmacol. 1992 Aug;106(4):853–858. doi: 10.1111/j.1476-5381.1992.tb14424.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hoiting B., Molleman A., Nelemans A., Den Hertog A. P2-purinoceptor-activated membrane currents and inositol tetrakisphosphate formation are blocked by suramin. Eur J Pharmacol. 1990 May 31;181(1-2):127–131. doi: 10.1016/0014-2999(90)90253-3. [DOI] [PubMed] [Google Scholar]
  13. Hourani S. M., Hall D. A., Nieman C. J. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate. Br J Pharmacol. 1992 Feb;105(2):453–457. doi: 10.1111/j.1476-5381.1992.tb14274.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Häggblad J., Heilbronn E. P2-purinoceptor-stimulated phosphoinositide turnover in chick myotubes. Calcium mobilization and the role of guanyl nucleotide-binding proteins. FEBS Lett. 1988 Aug 1;235(1-2):133–136. doi: 10.1016/0014-5793(88)81248-1. [DOI] [PubMed] [Google Scholar]
  15. Imboden J. B., Pattison G. Regulation of inositol 1,4,5-trisphosphate kinase activity after stimulation of human T cell antigen receptor. J Clin Invest. 1987 May;79(5):1538–1541. doi: 10.1172/JCI112986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Leeb-Lundberg L. M., Cotecchia S., Lomasney J. W., DeBernardis J. F., Lefkowitz R. J., Caron M. G. Phorbol esters promote alpha 1-adrenergic receptor phosphorylation and receptor uncoupling from inositol phospholipid metabolism. Proc Natl Acad Sci U S A. 1985 Sep;82(17):5651–5655. doi: 10.1073/pnas.82.17.5651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Leff P., Wood B. E., O'Connor S. E. Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery. Br J Pharmacol. 1990 Nov;101(3):645–649. doi: 10.1111/j.1476-5381.1990.tb14134.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Martin T. F., Lucas D. O., Bajjalieh S. M., Kowalchyk J. A. Thyrotropin-releasing hormone activates a Ca2+-dependent polyphosphoinositide phosphodiesterase in permeable GH3 cells. GTP gamma S potentiation by a cholera and pertussis toxin-insensitive mechanism. J Biol Chem. 1986 Feb 25;261(6):2918–2927. [PubMed] [Google Scholar]
  19. Molleman A., Hoiting B., Duin M., van den Akker J., Nelemans A., Den Hertog A. Potassium channels regulated by inositol 1,3,4,5-tetrakisphosphate and internal calcium in DDT1 MF-2 smooth muscle cells. J Biol Chem. 1991 Mar 25;266(9):5658–5663. [PubMed] [Google Scholar]
  20. Murrin R. J., Boarder M. R. Neuronal "nucleotide" receptor linked to phospholipase C and phospholipase D? Stimulation of PC12 cells by ATP analogues and UTP. Mol Pharmacol. 1992 Mar;41(3):561–568. [PubMed] [Google Scholar]
  21. O'Connor S. E., Dainty I. A., Leff P. Further subclassification of ATP receptors based on agonist studies. Trends Pharmacol Sci. 1991 Apr;12(4):137–141. doi: 10.1016/0165-6147(91)90530-6. [DOI] [PubMed] [Google Scholar]
  22. Pfeilschifter J. Comparison of extracellular ATP and UTP signalling in rat renal mesangial cells. No indications for the involvement of separate purino- and pyrimidino-ceptors. Biochem J. 1990 Dec 1;272(2):469–472. doi: 10.1042/bj2720469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Taylor S. J., Chae H. Z., Rhee S. G., Exton J. H. Activation of the beta 1 isozyme of phospholipase C by alpha subunits of the Gq class of G proteins. Nature. 1991 Apr 11;350(6318):516–518. doi: 10.1038/350516a0. [DOI] [PubMed] [Google Scholar]
  24. Thomas S. A., Zawisa M. J., Lin X., Hume R. I. A receptor that is highly specific for extracellular ATP in developing chick skeletal muscle in vitro. Br J Pharmacol. 1991 Aug;103(4):1963–1969. doi: 10.1111/j.1476-5381.1991.tb12360.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Uhing R. J., Prpic V., Jiang H., Exton J. H. Hormone-stimulated polyphosphoinositide breakdown in rat liver plasma membranes. Roles of guanine nucleotides and calcium. J Biol Chem. 1986 Feb 15;261(5):2140–2146. [PubMed] [Google Scholar]
  26. Van der Zee L., Nelemans A., Den Hertog A. Nucleotide receptors on DDT1 MF-2 vas deferens cells. Eur J Pharmacol. 1992 May 14;215(2-3):317–320. doi: 10.1016/0014-2999(92)90048-9. [DOI] [PubMed] [Google Scholar]
  27. Yaffe D., Saxel O. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature. 1977 Dec 22;270(5639):725–727. doi: 10.1038/270725a0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES